Artemis Medicare Services Limited (NSE:ARTEMISMED)
317.75
+4.25 (1.36%)
Nov 12, 2026, 3:30 PM IST
Artemis Medicare Services Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Artemis Medicare Services stock has a consensus rating of "Strong Buy" and an average price target of ₹356.00. The average 1-year stock price forecast is 12.04% higher than the current stock price, while the lowest is ₹330.00 (+3.86%) and the highest is ₹390.00 (+22.74%).
Price Target: ₹356.00 (+12.04%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Artemis Medicare Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 5 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 1 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
13.49B
from 10.81B
Increased by 24.79%
Revenue Next Year
17.10B
from 13.49B
Increased by 26.70%
EPS This Year
8.10
from 6.71
Increased by 20.81%
EPS Next Year
11.80
from 8.10
Increased by 45.68%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.